PlainRecalls
FDA Drug Critical Class I Ongoing

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).

Reported: January 24, 2024 Initiated: December 21, 2023 #D-0233-2024

Product Description

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).

Reason for Recall

Presence of Particulate Matter; identified as glass

Details

Recalling Firm
Pfizer Inc.
Units Affected
34000 Cartons
Distribution
Nationwide in the USA and Puerto Rico.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).. Recalled by Pfizer Inc.. Units affected: 34000 Cartons.
Why was this product recalled?
Presence of Particulate Matter; identified as glass
Which agency issued this recall?
This recall was issued by the FDA Drug on January 24, 2024. Severity: Critical. Recall number: D-0233-2024.